E-Home Household Service Holdings Limited (NASDAQ: EJH), a provider of integrated household services in China, today announced that it has begun to receive updates on the potential benefits of specific traditional Chinese medicine (TCM) herbs from its recently launched provisional study into feasible treatment applications of TCM for Monkeypox.
The company announced last month that it had begun a provisional investigation via its majority owned Zhongrun (Fujian) Pharmaceutical Co., Ltd. (“Zhongrun”), a leading medicine and personal care products operator in China. Since the initial announcement, Zhongrun has supplied leading hospitals, TCM study institutions and TCM pharmaceuticals companies various ranges of TCM herbs for the Monkeypox programs. Now, the company has begun to receive reports on the relative performance of specific TCM herbs in relation to the management and cessation of Monkeypox related symptoms. As such, Zhongrun will begin to selectively ramp up supply of the more beneficial TCM herbs to better foster more in-depth research in the search for a holistic and effective response to the rapidly spreading virus.
Mr. Wenshan Xie, Chairman and CEO of E-Home, commented: “By leveraging our relationship with Zhongrun, in conjunction with leading health professionals and organizations, we have been able to make rapid progress in creating a comprehensive response to the monkeypox virus. Preliminary results have shown that certain TCM treatments have a more robust effect on the symptoms shared by monkeypox infections, such as fever, headaches and exhaustion. With this data in mind, we are keen to make further revisions in our study to bring meaningful results and comprehensive treatment options to the public in the near future.”